Researchers at the University of Pennsylvania are now testing a non-invasive treatment – transcranial magnetic stimulation (TMS) – to target overactive areas in the brain responsible for tinnitus. TMS was recently approved by the United States Food and Drug Administration (FDA) for treatment of depression and has been extensively tested in Europe for tinnitus.
Michael Ruckenstein, MD, Professor of Otorhinolaryngology: Head and Neck Surgery at the University of Pennsylvania School of Medicine, will lead the study, in conjunction with John O’Reardon, Associate Professor of Psychiatry and Director of Penn’s Transcranial Magnetic Stimulation Program. Study participants will undergo 4 weeks (20 sessions) of TMS sessions to see if the treatment improves tinnitus. For those who respond, there will be a 3 month extension phase (8 sessions – 4 in month 1, 2 each in months 2 and 3).
Adults may be eligible for the trial if they have had chronic tinnitus for more than 6 months and do not have any neurological or psychiatric conditions. For more information on this study, please contact 215-746-7181.
PENN Medicine is a $3.6 billion enterprise dedicated to the related missions of medical education, biomedical research, and excellence in patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System.
Penn’s School of Medicine is currently ranked #3 in the nation in U.S.News & World Report’s survey of top research-oriented medical schools; and, according to the National Institutes of Health, received over $366 million in NIH grants (excluding contracts) in the 2008 fiscal year. Supporting 1,700 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.
The University of Pennsylvania Health System (UPHS) includes its flagship hospital, the Hospital of the University of Pennsylvania, rated one of the nation’s top ten “Honor Roll” hospitals by U.S.News & World Report; Pennsylvania Hospital, the nation’s first hospital; and Penn Presbyterian Medical Center, named one of the nation’s “100 Top Hospitals” for cardiovascular care by Thomson Reuters. In addition UPHS includes a primary-care provider network; a faculty practice plan; home care, hospice, and nursing home; three multispecialty satellite facilities; as well as the Penn Medicine at Rittenhouse campus, which offers comprehensive inpatient rehabilitation facilities and outpatient services in multiple specialties.